The
regulatory authority MHRA has issued guidance on GMP Data Integrity Definitions.
Data integrity is fundamental in a pharmaceutical quality system which ensures
that medicines are of the required quality.
The
new paper stated: “This document provides MHRA guidance on GMP data integrity
expectations for the pharmaceutical industry. This guidance is intended to
complement existing EU GMP relating to active substances and dosage forms, and
should be read in conjunction with national medicines legislation and the GMP
standards published in Eudralex volume 4.”
Posted by Tim Sandle
No comments:
Post a Comment
Pharmaceutical Microbiology Resources